CTOs on the Move


 
Olema is a preclinical biotechnology company developing new drugs for the treatment and prevention of estrogen receptor (ER) positive breast cancer. At Olema we leverage the exquisite knowledge of the molecular action of the ER to design compounds that are superior to both the current drugs and those in development.
  • Number of Employees: 25-100
  • Annual Revenue: $250-500 Million
  • www.olema.com
  • 665 3rd Street Suite 250
    San Francisco, CA USA 94107
  • Phone: n/a

Executives

Name Title Contact Details

Similar Companies

3B Medical

3B Medical, Inc. Focused on innovative solutions in sleep therapy, with an emphasis on improving patient compliance with design focused on patient comfort. NEW! Introducing iCode for Android & iPhone. (For use with all RESmart CPAP & Auto-CPAP mod...

Arizona Nutritional Supplements

Arizona Nutritional Supplements is a Chandler, AZ-based company in the Healthcare, Pharmaceuticals, and Biotech sector.

Friendly Farms

Friendly Farms is a licensed California cannabis manufacturing company that provides wellness and fitness services.

Pathalys

Pathalys Pharma, Inc. is a private, late-stage clinical biopharmaceutical company committed to the development of multiple advanced therapeutics that address unmet needs in the management of end stage kidney disease (ESKD). Pathalys` initial asset is upacicalcet, a novel calcimimetic with the potential to improve the treatment of SHPT in hemodialysis patients. Beyond upacicalcet, Pathalys continues to identify other high priority needs and potential solutions for patients with ESKD. Pathalys is headquartered in Research Triangle Park, North Carolina.

Medsite

Medsite is a New York, NY-based company in the Healthcare, Pharmaceuticals, and Biotech sector.